ARIXTRA Local Study For Registration In China.

NCT00328939 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism
Knee Replacement
Hip Replacement

Interventions

DRUG: ARIXTRA infusion
DRUG: Enoxaparine infusion

Sponsor

GlaxoSmithKline